Amir Goldkorn, MD
University of Southern California
2008
$
50000
Tower Career Development Grant
Targeting Prostate Cancer Stem Cells with Telomerase Interference
Will examine prostate cancer stem cells which may respond differently to therapy than the differentiated cancer cells, and attempt to determine their vulnerability to the target telomerase (increases chromosome size and thus extends cell longevity.)
Support the Journey
When you donate to Tower, you’re not supporting a single study. You’re part of an ecosystem that believes the next breakthrough is out there, waiting for someone to believe in it first. Every gift puts resources directly behind the discoveries that would otherwise never see the light of day.